In the studies that divided PCOS patients into sub-groups, depending on whether or not individuals exhibited features associated with metabolic syndrome, significantly higher Gal-3 levels have been observed in subjects with metabolic syndrome [129]. This evidence concerns the gene LGALS3 and metabolic syndrome.